As columnist Mary Shaniqua looks to the future, she remembers when she was far more active — and wonders if that could be a ...
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback